Personalized Cardiac Rehab Ups Survival in HF With Reduced EF

The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed.

Key Takeaways

  • Enrollment in a personalized, home-based multidisciplinary heart failure (HF) outreach program was associated with a significant reduction in all-cause mortality at a median of 2.6 years’ follow-up.

  • Participants also had fewer and shorter HF hospitalizations, and were more likely to be on guideline-directed medical therapy.

Why This Matters

  • HF is a global pandemic affecting at least 26 million people worldwide, and is increasing in prevalence.

  • HF survival remains worse than that of prostate, bowel, and breast cancers.

  • Previous research had demonstrated that multimodal, multidisciplinary cardiac rehabilitation programs are safe and improve exercise capacity and quality of life, but have not shown a significant, consistent reduction in mortality.

Study Design

  • This was an observational, registry-based study of adults with HF with reduced ejection fraction (

  • A total of 470 patients were enrolled in the outreach program and 348 were not.

  • The multidisciplinary intervention, led by a specialist HF nurse, included: regular home visits consisting of physical examination, fluid status assessment, and medication review; consistent education on medication compliance, side effects management, and support; dietary advice and education, including dietician home visits; prescribed physical exercises performed under supervision and tailored to individual patient needs.

  • Researchers examined all-cause mortality, rate of optimal medical therapy, HF hospitalizations, and total lengths of stay over a median of 978 days.

Key Results

  • The primary outcome of all-cause mortality was lower among enrolled vs non-enrolled patients (26% vs 38.2%; P <.001>

  • Enrolled patients had fewer recurrent HF admissions (>3 admissions; 16.2% vs 35.6%; P <.001>

  • Enrolled patients had reduced median admission days (14.5 vs 22 days; P <.001>

  • Enrolled patients were more likely to be on guideline-directed medical therapy (76.6% vs 56.6%; P <.001>

  • Enrollment status was the strongest independent predictor of survival (odds ratio , 0.606; P=.003), followed by statin therapy (OR, 0.682; P=.019).

Limitations

  • The analysis lacked randomization and was retrospective.

  • The non-enrolled cohort could have declined enrollment due to multiple factors, such as complex medical conditions, psychological and behavioral factors, and poor health literacy and adherence, which could have independently led to the observed worse outcomes.

  • Mortality data were collected from multiple sources, possibly introducing slight inaccuracies.

  • The outreach service is a labor- and expertise-intensive program that works well within its setting but could be difficult to replicate in other health systems with different economic structures, limiting the generalizability of the findings.

Disclosures

  • The study did not receive any funding.

  • The authors have declared no competing interest.

This is a summary of a preprint research report, “Personalised Cardiac Rehabilitation Outreach Service Reduces Mortality and Hospitalisations in Heart Failure with Reduced Ejection Fraction,” led by Zaidon Al-Falahi, MD, of the Campbelltown Hospital, Campbelltown, NSW, Australia on medRxiv, provided to you by Medscape. This study has not yet been peer reviewed. The full text can be found at medRxiv.org.

Follow Patrice Wendling on Twitter: @pwendl. For more from theheart.org | Medscape Cardiology, join us on Twitter and Facebook.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Which Apple iPhone 14 Should You Buy? thumbnail

Which Apple iPhone 14 Should You Buy?

It’s that time of the year. Indian consumers were among the first in the world to get their hands on the new iPhone 14 devices. India was among a list of 40-odd global markets where the iPhone 14, 14 Pro and Pro Max first went on sale on September 16. And now the iPhone 14
Read More
Electrolux Group Recalls Frigidaire Rear-Controlled Ranges Due to Electrical Shock and Electrocution Hazards thumbnail

Electrolux Group Recalls Frigidaire Rear-Controlled Ranges Due to Electrical Shock and Electrocution Hazards

This recall involves select Frigidaire brand rear-controlled ranges produced from October 2023 through November 2023 with electronic control panels and the following model and serial numbers within these ranges: Model NumberSerial Number RangeFCRE3052BWVF34618193 thru VF34618322FCRE305CBWVF34601466 thru VF34601608FCRG3051BBVF34508449 thru VF34508592, VF34521553 thru VF34521696, VF34521697 thru VF34521835FCRG3051BWVF34504801 thru VF34504942FCRE3062ABVF34424109 thru VF34424252FCRG3052BWVF34510705 thru VF34510818FCRE3052BBVF34414413 thru VF34414546, VF34600745 thru VF34600888, FCRE3052BSVF34413405 thru VF34413692FCRE306CASVF34410621 thru
Read More
세계일보가 달라집니다 thumbnail

세계일보가 달라집니다

세계일보가 2월 1일 창간 33돌을 맞아 새로운 모습으로 독자 여러분을 찾아갑니다. 오는 5월 출범하는 새 정부가 시급히 해결해야 할 과제들을 짚어보고 해법을 모색하는 연중기획물을 내보냅니다. 2014년부터 기후변화 의제를 선도해온 세계일보는 올해 기후환경 분야를 전담하는 ‘지구팀’을 신설해 심층 보도와 관련 포럼을 이어갑니다. 지방소멸의 위기를 진단하는 시리즈와 수교 30년을 맞은 한·중관계의 발전 방향도 모색합니다. 독자 여러분의 성원과…
Read More
The fast-growing need for oversight of AI in healthcare thumbnail

The fast-growing need for oversight of AI in healthcare

With artificial intelligence starting to proliferate in healthcare, and getting a lot of attention thanks to recent developments like ChatGPT, it's becoming critical that healthcare provider organizations understand the risks that come with AI and the subsequent need for oversight. Thomas F. O'Neil III is managing director at Berkeley Research Group and previously Cigna’s chief
Read More
Is It Time for Yet Another COVID Booster? thumbnail

Is It Time for Yet Another COVID Booster?

Is it time to get an additional COVID booster shot? The first COVID booster shot is now in the rear-view mirror for millions of Americans —for the 28% who got it, at least — but new data finds its effectiveness waning after about 4 months. The Centers for Disease Control and Prevention (CDC) has already…
Read More
Index Of News
Total
0
Share